Published on in Vol 4, No 3 (2015): Jul-Sep

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Dietary Advanced Glycation End Products Consumption as a Direct Modulator of Insulin Sensitivity in Overweight Humans: A Study Protocol for a Double-Blind, Randomized, Two Period Cross-Over Trial

Barbora de Courten   1 , MD,MPH,PhD,FRACP ;   Maximilian PJ de Courten   2 , MD,MPH ;   Casper G Schalkwijk   3 , PhD ;   Karen Z Walker   4 , BSc (Hons),MND,GradCert (Higher Ed),PhD ;   Josephine Forbes   5, 6 , PhD

1 Monash Centre for Health Research & Implementation, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

2 Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne, Australia

3 Laboratory for Metabolism and Vascular Medicine, Experimental Internal Medicine, Maastricht University, Maastricht, 6211 LK, Netherlands

4 Department of Nutrition and Dietetics, Monash University, Melbourne, Australia

5 Mater Research Institute- The University of Queensland, Glycation and Diabetes, TRI, South Brisbane, Australia

6 Mater Clinical School, School of Medicine, University of Queensland, St Lucia, Australia

Corresponding Author:

  • Barbora de Courten, MD,MPH,PhD,FRACP
  • Monash Centre for Health Research & Implementation
  • School of Public Health and Preventive Medicine
  • Monash University
  • 43-51 Kanooka Grove
  • Clayton
  • Melbourne, 3168
  • Australia
  • Phone: 61 3 9594 7086
  • Fax: 61 3 9594 7554
  • Email: barbora.decourten@monash.edu